Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2025-05-20 00:00:00 ET · period of report 2025-05-19 · accession 0001048477-25-000060 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-20 | 2025-05-19 | BMRN | Burkhart Erin | CAO, GVP | F - Tax | $59.27 | -996 | 16.0K | -6% | -$59.0K | |
| 2025-05-20 | 2025-05-20 | BMRN | Burkhart Erin | CAO, GVP | S - Sale | $59.31 | -1,786 | 14.2K | -11% | -$105.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-19 | F | D | 996 | $59.27 | 15,959 | D | — | — | |
| 2 | Common | Common Stock | 2025-05-20 | S | D | 1,786 | $59.31 | 14,173 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on November 26, 2024. |